Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer

Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.

Publication: Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer

Departments

School / College / Institute

Program

KU-Authors

KU Authors

Co-Authors

Editor & Affiliation

Compiler & Affiliation

Translator

Other Contributor

Date

Language

Type

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Source

Publisher

Subject

Citation

Has Part

Source

Book Series Title

Edition

DOI

URI

item.page.datauri

Link

Rights

Copyrights Note

Collections

Endorsement

Review

Supplemented By

Referenced By

Related Goal

3

Views

0

Downloads

Publication:
Empagliflozin-induced ketoacidosis in a patient presenting with new-onset type 2 diabetes mellitus due to indolent pancreatic cancer